NO20091735L - Radiofluorering - Google Patents
RadiofluoreringInfo
- Publication number
- NO20091735L NO20091735L NO20091735A NO20091735A NO20091735L NO 20091735 L NO20091735 L NO 20091735L NO 20091735 A NO20091735 A NO 20091735A NO 20091735 A NO20091735 A NO 20091735A NO 20091735 L NO20091735 L NO 20091735L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- radio fluorination
- labeled
- fluorination
- radio
- Prior art date
Links
- 238000003682 fluorination reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000002059 diagnostic imaging Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000000163 radioactive labelling Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0834—Compounds having one or more O-Si linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0896—Compounds with a Si-H linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/12—Organo silicon halides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Nuclear Medicine (AREA)
Abstract
Den foreliggende oppfinnelse vedrører nye forbindelser egnet for radioaktiv merking, eller allerede radioaktivt merket, med 18F, fremgangsmåter for fremstilling av slike forbindelser og anvendelse av slike forbindelser til diagnostisk avbilding. Slike merkede forbindelser er kjennetegnet ved formel II. Hvor restene F, R1,R2, B1,2,Y1,2, Z1,2 og E har betydningen som definert i beskrivelsen og kravene.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06076823A EP1908472A1 (en) | 2006-10-02 | 2006-10-02 | Silicon derivatives for PET imaging |
EP06076869A EP1911452A1 (en) | 2006-10-11 | 2006-10-11 | Silicon-derivates for PET-Imaging |
EP07090043A EP1970064A1 (en) | 2007-03-12 | 2007-03-12 | Silicon-derivatives for pet-imaging |
EP07090079A EP1985624A3 (en) | 2007-04-23 | 2007-04-23 | Single step method of radiofluorination of biologically active compounds or biomolecules |
PCT/EP2007/008044 WO2008040441A2 (en) | 2006-10-02 | 2007-09-07 | Silicon derivatives for pet imaging |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091735L true NO20091735L (no) | 2009-06-30 |
Family
ID=39030886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091735A NO20091735L (no) | 2006-10-02 | 2009-04-30 | Radiofluorering |
Country Status (21)
Country | Link |
---|---|
US (1) | US20090035215A1 (no) |
EP (1) | EP2074135A2 (no) |
JP (1) | JP2010505776A (no) |
KR (1) | KR20090085599A (no) |
AR (1) | AR062795A1 (no) |
AU (1) | AU2007304508A1 (no) |
BR (1) | BRPI0719956A2 (no) |
CA (1) | CA2664700A1 (no) |
CO (1) | CO6180444A2 (no) |
CR (1) | CR10703A (no) |
IL (1) | IL197817A0 (no) |
MA (1) | MA30824B1 (no) |
MX (1) | MX2009003617A (no) |
NO (1) | NO20091735L (no) |
PA (1) | PA8747601A1 (no) |
PE (1) | PE20081173A1 (no) |
SV (1) | SV2009003205A (no) |
TN (1) | TN2009000100A1 (no) |
TW (1) | TW200820988A (no) |
UY (1) | UY30596A1 (no) |
WO (1) | WO2008040441A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2529226B1 (en) * | 2010-01-25 | 2017-03-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Silylated biomolecules |
JP5717138B2 (ja) * | 2011-05-23 | 2015-05-13 | 独立行政法人産業技術総合研究所 | タンパク質固定化表面修飾材料 |
WO2014196540A1 (ja) * | 2013-06-06 | 2014-12-11 | 日産化学工業株式会社 | アルコキシシラン化合物、液晶配向剤、液晶配向膜及び液晶表示素子 |
US10800797B2 (en) | 2015-05-26 | 2020-10-13 | California Institute Of Technology | Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same |
GB2581619A (en) | 2017-09-15 | 2020-08-26 | Univ California | Inhibition of aminoacylase 3 (AA3) in the treatment of cancer |
US20230226228A1 (en) * | 2020-05-04 | 2023-07-20 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for detection of bacterial infection |
CN116075344A (zh) * | 2020-09-28 | 2023-05-05 | 国立研究开发法人量子科学技术研究开发机构 | 放射性标识物的制造方法、放射性标识物的制造装置以及放射性金属核素的蒸发浓缩方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084555A (en) * | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
US5732578A (en) * | 1995-02-24 | 1998-03-31 | Hyundai Metal Co., Ltd. | Device for maintaining the horizontality of a door lock lever |
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
US6639076B1 (en) * | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
WO2000076971A2 (en) * | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Serine protease inhibitors |
WO2002044144A2 (en) * | 2000-11-30 | 2002-06-06 | Advanced Research And Technology Institute, Inc. | Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
GB0206750D0 (en) * | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
EP1597270A2 (en) * | 2003-02-20 | 2005-11-23 | University of South Florida | Peptidomimetic inhibitors of stat3 activity and their medical uses |
GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
WO2005077967A1 (en) * | 2004-02-13 | 2005-08-25 | The University Of British Columbia | Radiolabeled compounds and compositions, their precursors and methods for their production |
US20080029548A1 (en) * | 2006-05-05 | 2008-02-07 | Ann De Wree | Fabric treatment dispensing package |
-
2007
- 2007-09-07 AU AU2007304508A patent/AU2007304508A1/en not_active Abandoned
- 2007-09-07 WO PCT/EP2007/008044 patent/WO2008040441A2/en active Application Filing
- 2007-09-07 EP EP07818173A patent/EP2074135A2/en not_active Withdrawn
- 2007-09-07 JP JP2009530773A patent/JP2010505776A/ja active Pending
- 2007-09-07 BR BRPI0719956-2A2A patent/BRPI0719956A2/pt not_active IP Right Cessation
- 2007-09-07 US US11/851,936 patent/US20090035215A1/en not_active Abandoned
- 2007-09-07 KR KR1020097009044A patent/KR20090085599A/ko not_active Application Discontinuation
- 2007-09-07 MX MX2009003617A patent/MX2009003617A/es not_active Application Discontinuation
- 2007-09-07 CA CA002664700A patent/CA2664700A1/en not_active Abandoned
- 2007-09-10 TW TW096133834A patent/TW200820988A/zh unknown
- 2007-09-14 UY UY30596A patent/UY30596A1/es not_active Application Discontinuation
- 2007-09-14 AR ARP070104086A patent/AR062795A1/es unknown
- 2007-09-14 PE PE2007001246A patent/PE20081173A1/es not_active Application Discontinuation
- 2007-09-14 PA PA20078747601A patent/PA8747601A1/es unknown
-
2009
- 2009-03-25 TN TN2009000100A patent/TN2009000100A1/fr unknown
- 2009-03-26 IL IL197817A patent/IL197817A0/en unknown
- 2009-04-01 CR CR10703A patent/CR10703A/es not_active Application Discontinuation
- 2009-04-02 CO CO09034043A patent/CO6180444A2/es not_active Application Discontinuation
- 2009-04-02 SV SV2009003205A patent/SV2009003205A/es not_active Application Discontinuation
- 2009-04-30 NO NO20091735A patent/NO20091735L/no not_active Application Discontinuation
- 2009-04-30 MA MA31834A patent/MA30824B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CR10703A (es) | 2009-06-25 |
JP2010505776A (ja) | 2010-02-25 |
WO2008040441A3 (en) | 2009-01-08 |
AU2007304508A1 (en) | 2008-04-10 |
EP2074135A2 (en) | 2009-07-01 |
WO2008040441A2 (en) | 2008-04-10 |
UY30596A1 (es) | 2008-05-02 |
AR062795A1 (es) | 2008-12-03 |
KR20090085599A (ko) | 2009-08-07 |
CA2664700A1 (en) | 2008-04-10 |
PA8747601A1 (es) | 2009-08-26 |
IL197817A0 (en) | 2009-12-24 |
BRPI0719956A2 (pt) | 2014-04-29 |
SV2009003205A (es) | 2009-10-19 |
US20090035215A1 (en) | 2009-02-05 |
AU2007304508A8 (en) | 2009-05-14 |
CO6180444A2 (es) | 2010-07-19 |
TN2009000100A1 (en) | 2010-08-19 |
TW200820988A (en) | 2008-05-16 |
MX2009003617A (es) | 2009-04-22 |
MA30824B1 (fr) | 2009-10-01 |
PE20081173A1 (es) | 2008-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091428L (no) | Forbindelser og metoder for 18F-merkede midler | |
NO20091735L (no) | Radiofluorering | |
NO20085004L (no) | Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler | |
NO20064826L (no) | Indazoler, benzotiazoler, benzoisotiazoler, benzisoksazoler og fremstilling og anvendelse derav | |
CR10694A (es) | Compuestos antagonistas del receptor de glucagon, composiciones que contienen dichos compuestos y procedimientos de uso | |
ATE555105T1 (de) | Heterocyclische fxr-bindende verbindungen | |
NO20055688L (no) | Organiske forbindelser | |
WO2010063700A8 (en) | Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides | |
ATE542543T1 (de) | Immunogene zusammensetzung, enthaltend ein adjuvans | |
FR2911866B1 (fr) | Solide cristalise izm-1 et son procede de preparation. | |
NO20083153L (no) | Kjemiske forbindelser | |
NO20081101L (no) | Regioselektiv metode for fremstilling av benzimidazol-tiofener | |
ATE536864T1 (de) | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung | |
MX2010009854A (es) | Agente para liberacion de sustancia funcional. | |
EP1917542A4 (en) | Method for tomographic inversion by matrix transformation | |
ATE459620T1 (de) | Benzimidazolthiophenverbindungen als plk- modulatoren | |
DE602006008639D1 (de) | Automatisches radioaktives markierungsverafhren | |
WO2009052970A3 (en) | Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors | |
WO2009127718A3 (en) | Novel microbiocides | |
FR2940266B1 (fr) | Solide cristallise im-20 et son procede de preparation | |
DE112006000984A5 (de) | Verfahren zur Herstellung von 2,5-substituierten Tetrahydropyran-Derivaten durch reduktive Eliminierung des entsprechenden 4-Halogen-Derivats | |
UA93870C2 (ru) | Меченные радиоактивным галогеном производные фенилоксианилина | |
AU2010332841A8 (en) | Prostate specific membrane antigen inhibitors | |
WO2006080043A3 (en) | Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation | |
NO20092813L (no) | Radiomerking via fluorinering av aziridiner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |